Results 1 to 3 of 3

Thread: Research and Markets: Global Spinal Cord Injury Therapeutics Pipeline Review 2014 - A

  1. #1
    Senior Member Moe's Avatar
    Join Date
    Sep 2012
    Location
    Springfield
    Posts
    493

    Research and Markets: Global Spinal Cord Injury Therapeutics Pipeline Review 2014 - A

    April 22, 2014 06:20 PM Eastern Daylight Time

    DUBLIN--Research and Markets

    Spinal Cord Injury - Pipeline Review, H1 2014
    This report provides comprehensive information on the therapeutic development for Spinal Cord Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Cord Injury and special features on late-stage and discontinued projects.
    The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
    Scope

    • The report provides a snapshot of the global therapeutic landscape of Spinal Cord Injury
    • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
    • The report reviews key players involved in the therapeutics development for Spinal Cord Injury and enlists all their major and minor projects
    • The report summarizes all the dormant and discontinued pipeline projects
    • A review of the Spinal Cord Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
    • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
    • A detailed assessment of monotherapy and combination therapy pipeline projects
    • Coverage of the Spinal Cord Injury pipeline on the basis of target, MoA, route of administration and molecule type
    • Latest news and deals relating related to pipeline products

    For more information visit http://www.researchandmarkets.com/re...2s/spinal_cord

    Contacts Research and Markets
    Laura Wood, Senior Manager.
    press@researchandmarkets.com
    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716
    Sector: Central Nervous System

    Source: http://www.businesswire.com/news/hom...s#.U1ffmFVdWSo
    Last edited by Moe; 04-23-2014 at 11:48 AM. Reason: formatting

  2. #2
    Do I give you the $2000 Moe for this "Report"? Do you at least get a cut for such a well formatted ADVERTISING? WTF man? Why the blatant hustle?
    ______
    Awe at my magnificent coq!

    "You may say I'm a dreamer
    but I'm not" - J. Lennon

  3. #3
    Senior Member Moe's Avatar
    Join Date
    Sep 2012
    Location
    Springfield
    Posts
    493
    Quote Originally Posted by eks View Post
    Do I give you the $2000 Moe for this "Report"? Do you at least get a cut for such a well formatted ADVERTISING? WTF man? Why the blatant hustle?
    ???? - I have no idea what you're trying to say or acuse me of... these are simply copy/paste of news articles, I share them here to keep us here in the SCI community informed, just like the other sci related articles... Would you please clarify what you're trying to say and what is the problem?

Similar Threads

  1. Replies: 0
    Last Post: 06-14-2012, 10:57 AM
  2. Replies: 3
    Last Post: 05-14-2012, 06:23 AM
  3. Replies: 0
    Last Post: 07-07-2011, 08:59 PM
  4. Replies: 0
    Last Post: 05-30-2011, 10:49 AM
  5. Replies: 12
    Last Post: 04-09-2006, 01:23 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •